Cover Image

Cost‐effectiveness analysis of a biopsy‐free diagnostic strategy for prostate cancer using mpMRI and PSMA‐PET/CT

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Joshua Yi Min Tung, Rachel Shu‐En Lau, Edmund Pek Siang Teo, Kit Mun Chow, Julene Hui Wun Ong, Timothy Siliang Lu, Weiren Chen, Jingqiu Li, Xinyan Yang, Alvin Yuanming Lee, Yu Guang Tan, Kae Jack Tay, Sue Ping Thang, Winnie Wing Chuen Lam, Yan Mee Law, Henry Sun Sien Ho, Christopher Wai Sam Cheng, John Shyi‐Peng Yuen, Kenneth Chen
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	BJUI Compass
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Multivariable model integrating PHI and mpMRI for detecting csPCa in biopsy‐naïve men
by: Mario Dominguez Esteban, et al.
Published: (2025)

Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
by: Arjun Pon Avudaiappan, et al.
Published: (2024)

Does total lesion prostate‐specific membrane antigen (PSMA) activity on 68Ga‐PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer?
by: Jeremy Cheng, et al.
Published: (2025)

The impact of biopsy core length on the discrepancy in Gleason scores between biopsy and radical prostatectomy specimen
by: Cheng‐hao Guo, et al.
Published: (2025)

The carbon footprint of transperineal prostate biopsy
by: Daniel A. Carson, et al.
Published: (2025)

Quantification of perineural invasion on prostate biopsy improves risk stratification in biopsy Grade Group 2–3 cancer
by: Yuki Teramoto, et al.
Published: (2026)

PSMA PET/CT findings in high‐risk biochemical recurrence after local treatment of prostate cancer
by: Nicole Handa, et al.
Published: (2025)

Multiparametric‐magnetic resonance imaging (mp‐MRI) of the prostate and Urolift: Identifying artefact size, location and clinical implications
by: Cameron James Parkin, et al.
Published: (2024)

A population‐based analyses of the evolving management of cN1M0 prostate cancer in the PSMA‐PET era
by: Jennifer Ward, et al.
Published: (2025)

Perioperative antibiotic prophylaxis, prostate size and transperineal prostate biopsy
by: Maxwell Louis Sandberg, et al.
Published: (2026)

Anatomical distribution of disease in pN1 prostate cancer with BCR post‐RP: A PSMA‐PET/CT‐based analysis
by: Lotte G. Zuur, et al.
Published: (2025)

A modified Delphi consensus statement on the role of biopsy in small renal masses
by: Darryl E. Bernstein, et al.
Published: (2025)

Risk factors of negative prostate biopsies: A CHAID decision tree analysis
by: Pierre Allainguillaume, et al.
Published: (2026)

AI‐enhanced micro‐ultrasound improves detection of clinically significant prostate cancer at biopsy
by: Muhammad Imran, et al.
Published: (2026)

Perioperative alpha blockers in voiding dysfunction secondary to prostate biopsy: A meta‐analysis
by: Sean Lim, et al.
Published: (2024)

Contemporary assessment of diagnostic performance and histologic concordance of renal mass biopsy with surgical pathology
by: Mitchell M. Huang, et al.
Published: (2025)

Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
by: Esther H. J. Hamoen, et al.
Published: (2025)

Clinical validation of a biopsy‐based six‐gene signature prognostic for aggressive prostate cancer
by: Agnieszka Krzyzanowska, et al.
Published: (2024)

Transperineal prostate biopsy with freehand technique under local anaesthetic: A systematic review and meta‐analysis
by: Benjamin M. Mac Curtain, et al.
Published: (2025)

The impact of pre‐biopsy MRI and additional testing on prostate cancer screening outcomes: A rapid review
by: Abel Tesfai, et al.
Published: (2024)

Concordance with final pathology when transitioning from standard transrectal to cognitive targeted transperineal prostate biopsy
by: Alfred Honoré, et al.
Published: (2025)

Omission of contralateral biopsies in unilateral MRI‐suspicious prostate cancer has minimal impact on clinical risk assessment
by: Stijn M. van den Bosch, et al.
Published: (2026)

Comparative analysis of early outcomes of the first 150 cases of posterior approach robotic‐assisted radical prostatectomy and identification of the learning curve: A single‐surgeon series
by: Li June Tay, et al.
Published: (2025)

Oncological outcomes post focal low‐dose‐rate brachytherapy in low‐intermediate risk prostate cancer
by: Mohammadmehdi Adhami, et al.
Published: (2026)

Targeting genomic receptors in voided urine for confirmation of benign prostatic hyperplasia
by: Mathew Thakur, et al.
Published: (2024)

Giant testicular germ‐cell tumours—An analysis of relative incidence and clinical features based on a clinical case series and a survey of the literature
by: Markus Angerer, et al.
Published: (2026)

Prognostic factors and treatment impact on overall survival in patients with renal neuroendocrine tumour
by: Olamide O. Omidele, et al.
Published: (2024)

Recurrence patterns following nephrectomy for renal cell carcinoma in a Danish nationwide cohort
by: Goran Bencina, et al.
Published: (2024)

Prevention of lymphoceles using peritoneal flaps during robotic‐assisted radical prostatectomy with pelvic lymph node dissection: A systematic review and meta‐analysis
by: Huseyin Yildiz, et al.
Published: (2026)

Treatment decision regret after precision prostatectomy: An analysis of patient‐reported outcomes predicting decision regret
by: Kaushik P. Kolanukuduru, et al.
Published: (2024)

Issue Information
Published: (2025)

Step‐by‐step: A traction‐based fenestration method for vasoepididymostomy
by: Kosuke Kojo, et al.
Published: (2025)

Increased risk of bleeding during and after HoLEP in patients with prostate cancer: A multicentre comparative cohort study
by: Angelo Porreca, et al.
Published: (2025)

Competing risk of death in patients with low, intermediate and high risk of recurrence after radical surgery for clear cell renal cell carcinoma
by: Anna Brännbäck, et al.
Published: (2025)

Urinary microbiota diversity and composition in patients with advanced renal cell cancer
by: Frederico Leal, et al.
Published: (2026)

Racial and socioeconomic disparities in surgical care for post‐prostate cancer treatment complications: A nationwide Medicare‐based analysis
by: Oluwafolajimi Adesanya, et al.
Published: (2024)

Reduced p63 expression is linked to unfavourable prognosis in muscle‐invasive urothelial carcinoma of the bladder
by: Kira Furlano, et al.
Published: (2024)

A systematic review of the patient reported outcomes that affect patients with muscle invasive bladder cancer after radical cystectomy and urinary diversion
by: John Lahoud, et al.
Published: (2024)

The learning curve of single‐port extraperitoneal robotic radical prostatectomy: Initial experience and outcomes from a newly graduated fellowship‐trained robotic surgeon
by: Jacob S. Hershenhouse, et al.
Published: (2026)

Improving clinical efficiency using retrieval‐augmented generation in urologic oncology: A guideline‐enhanced artificial intelligence approach
by: Harry Collin, et al.
Published: (2024)